A US National Institutes of Health grant will fund an [...]

The FDA has cleared Sapience Therapeutics to begin clinical development [...]

ALK’s 2mg nasal adrenaline spray has been recommended for use [...]

Resolution Therapeutics has partnered with Blood Centers of America to [...]

Resolution Therapeutics has treated the final patient in its Phase [...]

ENA Respiratory has begun dosing participants in Part B of [...]

AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]

Karyopharm Therapeutics has submitted an application to the FDA seeking [...]

Early Phase 1b data show five objective responses among six [...]

The US Food and Drug Administration (FDA) has approved Mimrylo [...]